Taysha Gene Therapies, Inc. ($TSHA)
Filing Information
| Accession Number | 0001665124-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
238,042
Total Value
$924,525.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 10, 2026 | Exercise/Conversion | 19,021 | $1.71 | $32,525.91 | 1,336,410 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 10, 2026 | Sale | 200,000 | $4.46 | $892,000.00 | 1,136,410 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Apr 10, 2026 | Exercise/Conversion | 19,021 | $0.00 | $0.00 | 455,920 | Direct | โ | View Details |